Table 1.
Pre-operative, intra-operative, and postoperative variables analyzed.
| Patients |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All patients (Groups 1–5) |
1–30 (Group 1) |
31–60 (Group 2) |
61–90 (Group 3) |
91–120 (Group 4) |
121–150 (Group 5) |
p | |||||||
| n | % | n | % | n | % | n | % | n | % | n | % | ||
| Major | 26 | 17.3 | 1 | 3.3 | 3 | 10.0 | 6 | 20.0 | 9 | 30.0 | 7 | 23.3 | 0.05 |
| Malignancy | 114 | 76.0 | 24 | 80.0 | 28 | 93.3 | 24 | 80.0 | 19 | 63.3 | 19 | 63.3 | 0.03 |
| ASA score >2 | 61 | 40.7 | 8 | 5.3 | 13 | 8.6 | 14 | 9.3 | 14 | 9.3 | 12 | 8.0 | 0.46 |
| CCI = 2 | 147 | 98.0 | 29 | 96.7 | 30 | 100.0 | 29 | 96.7 | 30 | 100.0 | 29 | 96.7 | |
| EBL (ml) | 449.6 ± 748.0 | 449.4 ± 504.9 | 845.3 ± 1348.9 | 359 ± 433.8 | 421.7 ± 601.4 | 197.7 ± 276.6 | |||||||
| Transfusions intraOP | 13 | 8.7 | 4 | 13.3 | 5 | 16.6 | 2 | 6.6 | 2 | 6.6 | 0 | 0.0 | 0.46 |
| Transfusions postOP | 10 | 6.7 | 3 | 10.0 | 4 | 13.3 | 2 | 6.6 | 1 | 3.3 | 0 | 0.0 | 0.37 |
| Transfused intra/postoOP | 14 | 9.3 | 4 | 13.3 | 5 | 16.6 | 3 | 10.0 | 2 | 6.6 | 0 | 0.0 | 0.43 |
| Op length (min) ± SD | 188.3 ± 126.1 | 180.3 ± 109.6 | 199.4 ± 130.6 | 173.8 ± 100.0 | 226.7 ± 178.4 | 163.7 ± 97.5 | |||||||
| Complications | 17 | 11.3 | 6 | 20.0 | 1 | 3.3 | 3 | 10.0 | 3 | 10.0 | 4 | 13.3 | 0.36 |
| LOS ≤3 days | 62 | 41.3 | 6 | 20.7 | 5 | 8.1 | 18 | 60.0 | 14 | 48.3 | 19 | 63.3 | 0.00 |